Linda Coley Sewell Distinguished Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
Dr. Saira Sheikh is the Linda Coley Sewell Distinguished Professor of Medicine at the University of North Carolina at Chapel Hill. She is trained and board certified in Internal Medicine, Allergy/Immunology and Rheumatology. She is the Director of the Clinical Trials Program at the University of North Carolina's (UNC) Thurston Arthritis Research Center (TARC), as well as the UNC Rheumatology Lupus Clinic. Her work focuses on answering scientific questions that directly impact the care of patients with complex immunologic diseases. She is also leading national initiatives to develop real-world, practical models to promote inclusion of minority patients in lupus clinical trials, particularly using technology-based applications. She is Vice-Chair of the Lupus Clinical Investigators Network (LuCIN). She currently serves on the Medical-Scientific Advisory Council for the Lupus Foundation of America.
Lessons from the PALS Program on Increasing Diversity in SLE Trials
Monday, November 18, 2024
10:45 AM – 11:00 AM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Terminated, May 31, 2024); biogen: Consultant (Ongoing); Cabaletta Bio: Consultant (Terminated, December 31, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing)
Monday, November 18, 2024
11:15 AM – 11:30 AM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Terminated, May 31, 2024); biogen: Consultant (Ongoing); Cabaletta Bio: Consultant (Terminated, December 31, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing)
18M28: Are We Putting the CAR-T Before the Horse?
Monday, November 18, 2024
1:00 PM – 2:00 PM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Terminated, May 31, 2024); biogen: Consultant (Ongoing); Cabaletta Bio: Consultant (Terminated, December 31, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing)